Cargando…
Prediction of effective humoral response to SARS-CoV-2 vaccines in healthy subjects by cortical thickness of post-vaccination reactive lymphadenopathy
PURPOSE: To study the association between ultrasound cortical thickness in reactive post-vaccination lymph nodes and the elicited humoral response and to evaluate the performance of cortical thickness as a predictor of vaccine effectiveness in patients with and without a previous history of COVID-19...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159827/ https://www.ncbi.nlm.nih.gov/pubmed/37142867 http://dx.doi.org/10.1007/s00330-023-09662-5 |
_version_ | 1785037176857165824 |
---|---|
author | Igual-Rouilleault, Alba Cristina Soriano, Ignacio Quan, Paola Leonor Reina, Gabriel del Pozo, José Luis Gónzalez, Álvaro Fernández-Ciriza, Leire Fernández-Montero, Alejandro Pina, Luis Elizalde, Arlette |
author_facet | Igual-Rouilleault, Alba Cristina Soriano, Ignacio Quan, Paola Leonor Reina, Gabriel del Pozo, José Luis Gónzalez, Álvaro Fernández-Ciriza, Leire Fernández-Montero, Alejandro Pina, Luis Elizalde, Arlette |
author_sort | Igual-Rouilleault, Alba Cristina |
collection | PubMed |
description | PURPOSE: To study the association between ultrasound cortical thickness in reactive post-vaccination lymph nodes and the elicited humoral response and to evaluate the performance of cortical thickness as a predictor of vaccine effectiveness in patients with and without a previous history of COVID-19 infection. METHODS: A total of 156 healthy volunteers were recruited and followed prospectively after receiving two COVID-19 vaccination doses using different protocols. Within a week after receiving the second dose, an axillary ultrasound of the ipsilateral vaccinated arm was performed, and serial post-vaccination serologic tests (PVST) were collected. Maximum cortical thickness was chosen as a nodal feature to analyze association with humoral immunity. Total antibodies quantified during consecutive PVST in previously-infected patients and in coronavirus-naïve volunteers were compared (Mann–Whitney U test). The association between hyperplastic-reactive lymph nodes and effective humoral response was studied (odds ratio). The performance of cortical thickness in detecting vaccination effectiveness was evaluated (area under the ROC curve). RESULTS: Significantly higher values for total antibodies were observed in volunteers with a previous history of COVID-19 infection (p < 0.001). The odds ratio associating immunized coronavirus-naïve volunteers after 90 and 180 days of the second dose with a cortical thickness ≥ 3 mm was statistically significant (95% CI 1.52–6.97 and 95% CI 1.47–7.29, respectively). The best AUC result was obtained comparing antibody secretion of coronavirus-naïve volunteers at 180 days (0.738). CONCLUSIONS: Ultrasound cortical thickness of reactive lymph nodes in coronavirus-naïve patients may reflect antibody production and a long-term effective humoral response elicited by vaccination. CLINICAL RELEVANCE STATEMENT: In coronavirus-naïve patients, ultrasound cortical thickness of post-vaccination reactive lymphadenopathy shows a positive association with protective antibody titers against SARS-CoV-2, especially in the long term, providing new insights into previous publications. KEY POINTS: • Hyperplastic lymphadenopathy was frequently observed after COVID-19 vaccination. • Ultrasound cortical thickness of reactive post-vaccine lymph nodes may reflect a long-term effective humoral response in coronavirus-naïve patients. |
format | Online Article Text |
id | pubmed-10159827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-101598272023-05-09 Prediction of effective humoral response to SARS-CoV-2 vaccines in healthy subjects by cortical thickness of post-vaccination reactive lymphadenopathy Igual-Rouilleault, Alba Cristina Soriano, Ignacio Quan, Paola Leonor Reina, Gabriel del Pozo, José Luis Gónzalez, Álvaro Fernández-Ciriza, Leire Fernández-Montero, Alejandro Pina, Luis Elizalde, Arlette Eur Radiol Breast PURPOSE: To study the association between ultrasound cortical thickness in reactive post-vaccination lymph nodes and the elicited humoral response and to evaluate the performance of cortical thickness as a predictor of vaccine effectiveness in patients with and without a previous history of COVID-19 infection. METHODS: A total of 156 healthy volunteers were recruited and followed prospectively after receiving two COVID-19 vaccination doses using different protocols. Within a week after receiving the second dose, an axillary ultrasound of the ipsilateral vaccinated arm was performed, and serial post-vaccination serologic tests (PVST) were collected. Maximum cortical thickness was chosen as a nodal feature to analyze association with humoral immunity. Total antibodies quantified during consecutive PVST in previously-infected patients and in coronavirus-naïve volunteers were compared (Mann–Whitney U test). The association between hyperplastic-reactive lymph nodes and effective humoral response was studied (odds ratio). The performance of cortical thickness in detecting vaccination effectiveness was evaluated (area under the ROC curve). RESULTS: Significantly higher values for total antibodies were observed in volunteers with a previous history of COVID-19 infection (p < 0.001). The odds ratio associating immunized coronavirus-naïve volunteers after 90 and 180 days of the second dose with a cortical thickness ≥ 3 mm was statistically significant (95% CI 1.52–6.97 and 95% CI 1.47–7.29, respectively). The best AUC result was obtained comparing antibody secretion of coronavirus-naïve volunteers at 180 days (0.738). CONCLUSIONS: Ultrasound cortical thickness of reactive lymph nodes in coronavirus-naïve patients may reflect antibody production and a long-term effective humoral response elicited by vaccination. CLINICAL RELEVANCE STATEMENT: In coronavirus-naïve patients, ultrasound cortical thickness of post-vaccination reactive lymphadenopathy shows a positive association with protective antibody titers against SARS-CoV-2, especially in the long term, providing new insights into previous publications. KEY POINTS: • Hyperplastic lymphadenopathy was frequently observed after COVID-19 vaccination. • Ultrasound cortical thickness of reactive post-vaccine lymph nodes may reflect a long-term effective humoral response in coronavirus-naïve patients. Springer Berlin Heidelberg 2023-05-05 2023 /pmc/articles/PMC10159827/ /pubmed/37142867 http://dx.doi.org/10.1007/s00330-023-09662-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Breast Igual-Rouilleault, Alba Cristina Soriano, Ignacio Quan, Paola Leonor Reina, Gabriel del Pozo, José Luis Gónzalez, Álvaro Fernández-Ciriza, Leire Fernández-Montero, Alejandro Pina, Luis Elizalde, Arlette Prediction of effective humoral response to SARS-CoV-2 vaccines in healthy subjects by cortical thickness of post-vaccination reactive lymphadenopathy |
title | Prediction of effective humoral response to SARS-CoV-2 vaccines in healthy subjects by cortical thickness of post-vaccination reactive lymphadenopathy |
title_full | Prediction of effective humoral response to SARS-CoV-2 vaccines in healthy subjects by cortical thickness of post-vaccination reactive lymphadenopathy |
title_fullStr | Prediction of effective humoral response to SARS-CoV-2 vaccines in healthy subjects by cortical thickness of post-vaccination reactive lymphadenopathy |
title_full_unstemmed | Prediction of effective humoral response to SARS-CoV-2 vaccines in healthy subjects by cortical thickness of post-vaccination reactive lymphadenopathy |
title_short | Prediction of effective humoral response to SARS-CoV-2 vaccines in healthy subjects by cortical thickness of post-vaccination reactive lymphadenopathy |
title_sort | prediction of effective humoral response to sars-cov-2 vaccines in healthy subjects by cortical thickness of post-vaccination reactive lymphadenopathy |
topic | Breast |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159827/ https://www.ncbi.nlm.nih.gov/pubmed/37142867 http://dx.doi.org/10.1007/s00330-023-09662-5 |
work_keys_str_mv | AT igualrouilleaultalbacristina predictionofeffectivehumoralresponsetosarscov2vaccinesinhealthysubjectsbycorticalthicknessofpostvaccinationreactivelymphadenopathy AT sorianoignacio predictionofeffectivehumoralresponsetosarscov2vaccinesinhealthysubjectsbycorticalthicknessofpostvaccinationreactivelymphadenopathy AT quanpaolaleonor predictionofeffectivehumoralresponsetosarscov2vaccinesinhealthysubjectsbycorticalthicknessofpostvaccinationreactivelymphadenopathy AT reinagabriel predictionofeffectivehumoralresponsetosarscov2vaccinesinhealthysubjectsbycorticalthicknessofpostvaccinationreactivelymphadenopathy AT delpozojoseluis predictionofeffectivehumoralresponsetosarscov2vaccinesinhealthysubjectsbycorticalthicknessofpostvaccinationreactivelymphadenopathy AT gonzalezalvaro predictionofeffectivehumoralresponsetosarscov2vaccinesinhealthysubjectsbycorticalthicknessofpostvaccinationreactivelymphadenopathy AT fernandezcirizaleire predictionofeffectivehumoralresponsetosarscov2vaccinesinhealthysubjectsbycorticalthicknessofpostvaccinationreactivelymphadenopathy AT fernandezmonteroalejandro predictionofeffectivehumoralresponsetosarscov2vaccinesinhealthysubjectsbycorticalthicknessofpostvaccinationreactivelymphadenopathy AT pinaluis predictionofeffectivehumoralresponsetosarscov2vaccinesinhealthysubjectsbycorticalthicknessofpostvaccinationreactivelymphadenopathy AT elizaldearlette predictionofeffectivehumoralresponsetosarscov2vaccinesinhealthysubjectsbycorticalthicknessofpostvaccinationreactivelymphadenopathy |